Authors
Mariana Fernández, Karina Cardone, Susana Avila, Maria Victoria Periago, Hugo Krupitzki, Pablo Piorno, Analia Guilera, Maria Gabriela Dorigato, Ariel Sosa, Marina Gold, Favio Crudo
Published in
BMJ public health. Volume 4. Issue 4. Pages e004551. Epub Nov 16, 2026.
Abstract
Describe and report the implementation of the framework for elimination of mother-to-child transmission (EMTCT) Plus, aimed at eliminating MTCT of HIV, syphilis, hepatitis B virus (HBV) and Chagas disease (ChD), in the rural binational Gran Chaco region between Argentina and Paraguay, including data on the prevalence, treatment and follow-up of mothers, their newborns (NBs) and their previous children.
This initiative was implemented as a public-private partnership through continuous actions performed by local health personnel and periodic actions by a specialised health team, as part of antenatal care (ANC) through a retrospective cross-sectional study.
Implementation data from June 2018 up to December 2024 obtained through ANC performed in all the health posts, hospitals from the regions as well as through household visits.
A total of 2664 pregnant women (mean age 24±7 years; 77.9% of indigenous origin) were enrolled, achieving >95% ANC coverage annually. Over the study period, the prevalence of Trypanosoma cruzi, causative agent of ChD, was 2.6% (68/2664; 95% CI 2.0 to 3.2), with annual rates decreasing from 4.7% (2019) to 1.7% (2024). Among NBs of T. cruzi-positive mothers, 14.7% (11/75) were diagnosed with congenital infection. In previously born children of seropositive mothers, the prevalence was 7.9%. Syphilis prevalence among pregnant women was 0.8% (21/2,664), with a rising trend from 0.5% (2018) to 1.4% (2024); no congenital syphilis cases were detected. No cases of HIV or hepatitis B were identified, consistent with the high vaccination coverage for HBV (>95%) and low prevalence in this region. Despite high detection and case management, only 58% of postpartum T. cruzi-positive women completed aetiological treatment, compared with 100% of positive NBs and 84.6% of previously born positive children.
This comprehensive, patient-centred model succeeded in achieving diagnostic, coverage and treatment targets for neonates and children, but highlighted persistent challenges in postpartum maternal treatment adherence in the context of high population mobility and socio-environmental vulnerability.
PMID:
43048161
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0